105 related articles for article (PubMed ID: 36694315)
1. Design and Construction of Carboxylesterase 2c Gene Knockout Rats by CRISPR/Cas9.
Liu J; Shang X; Yao B; Zhang Y; Huang S; Guo Y; Wang X
Curr Drug Metab; 2023; 24(3):190-199. PubMed ID: 36694315
[TBL] [Abstract][Full Text] [Related]
2. Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene.
Liu J; Shang X; Huang S; Xu Y; Lu J; Zhang Y; Liu Z; Wang X
Mol Pharmacol; 2021 Nov; 100(5):480-490. PubMed ID: 34503976
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Novel
Sun D; Lu J; Zhang Y; Liu J; Liu Z; Yao B; Guo Y; Wang X
Drug Metab Dispos; 2021 Aug; 49(8):638-647. PubMed ID: 34074728
[TBL] [Abstract][Full Text] [Related]
4. Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model.
Lu J; Chen A; Ma X; Shang X; Zhang Y; Guo Y; Liu M; Wang X
Drug Metab Dispos; 2020 Nov; 48(11):1129-1136. PubMed ID: 32878767
[TBL] [Abstract][Full Text] [Related]
5. Intestine-Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet-Induced Liver Steatosis and Obesity.
Maresch LK; Benedikt P; Feiler U; Eder S; Zierler KA; Taschler U; Kolleritsch S; Eichmann TO; Schoiswohl G; Leopold C; Wieser BI; Lackner C; Rülicke T; van Klinken J; Kratky D; Moustafa T; Hoefler G; Haemmerle G
Hepatol Commun; 2019 Feb; 3(2):227-245. PubMed ID: 30766961
[TBL] [Abstract][Full Text] [Related]
6. Carboxylesterase 2 proteins are efficient diglyceride and monoglyceride lipases possibly implicated in metabolic disease.
Chalhoub G; Kolleritsch S; Maresch LK; Taschler U; Pajed L; Tilp A; Eisner H; Rosina P; Kien B; Radner FPW; Schicho R; Oberer M; Schoiswohl G; Haemmerle G
J Lipid Res; 2021; 62():100075. PubMed ID: 33872605
[TBL] [Abstract][Full Text] [Related]
7. Development and Characterization of MDR1 (
Liang C; Zhao J; Lu J; Zhang Y; Ma X; Shang X; Li Y; Ma X; Liu M; Wang X
Drug Metab Dispos; 2019 Feb; 47(2):71-79. PubMed ID: 30478157
[TBL] [Abstract][Full Text] [Related]
8. The Crystal Structure of Mouse Ces2c, a Potential Ortholog of Human CES2, Shows Structural Similarities in Substrate Regulation and Product Release to Human CES1.
Eisner H; Riegler-Berket L; Gamez CFR; Sagmeister T; Chalhoub G; Darnhofer B; Jazleena PJ; Birner-Gruenberger R; Pavkov-Keller T; Haemmerle G; Schoiswohl G; Oberer M
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361897
[TBL] [Abstract][Full Text] [Related]
9. Characterization of novel cytochrome P450 2E1 knockout rat model generated by CRISPR/Cas9.
Wang X; Tang Y; Lu J; Shao Y; Qin X; Li Y; Wang L; Li D; Liu M
Biochem Pharmacol; 2016 Apr; 105():80-90. PubMed ID: 26947455
[TBL] [Abstract][Full Text] [Related]
10. CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research.
Lu J; Shao Y; Qin X; Liu D; Chen A; Li D; Liu M; Wang X
Sci Rep; 2017 Feb; 7():42922. PubMed ID: 28218310
[TBL] [Abstract][Full Text] [Related]
11. Development and initial characterization of a novel ghrelin receptor CRISPR/Cas9 knockout wistar rat model.
Zallar LJ; Tunstall BJ; Richie CT; Zhang YJ; You ZB; Gardner EL; Heilig M; Pickel J; Koob GF; Vendruscolo LF; Harvey BK; Leggio L
Int J Obes (Lond); 2019 Feb; 43(2):344-354. PubMed ID: 29453460
[TBL] [Abstract][Full Text] [Related]
12. Generation of Caco-2 cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system.
Yamada N; Negoro R; Watanabe K; Fujita T
Drug Metab Pharmacokinet; 2023 Jun; 50():100497. PubMed ID: 37037169
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells.
Mandl M; Ritthammer H; Ejaz A; Wagner SA; Hatzmann FM; Baumgarten S; Viertler HP; Zwierzina ME; Mattesich M; Schiller V; Rauchenwald T; Ploner C; Waldegger P; Pierer G; Zwerschke W
Adipocyte; 2020 Dec; 9(1):626-635. PubMed ID: 33070670
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated
Izumi R; Kusakabe T; Noguchi M; Iwakura H; Tanaka T; Miyazawa T; Aotani D; Hosoda K; Kangawa K; Nakao K
J Lipid Res; 2018 Sep; 59(9):1575-1585. PubMed ID: 30042156
[TBL] [Abstract][Full Text] [Related]
15. Carboxylesterase-2 plays a critical role in dabigatran etexilate active metabolite formation.
Laizure SC; Chen F; Farrar JE; Ali D; Yang B; Parker RB
Drug Metab Pharmacokinet; 2022 Dec; 47():100479. PubMed ID: 36375226
[TBL] [Abstract][Full Text] [Related]
16. Analysis of carboxylesterase 2 transcript variants in cynomolgus macaque liver.
Uno Y; Igawa Y; Tanaka M; Ohura K; Hosokawa M; Imai T
Xenobiotica; 2019 Feb; 49(2):247-255. PubMed ID: 29384423
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of carboxylesterases 1 and 2 plays an important role in prodrug metabolism in immunological liver injury rats.
Zhang C; Xu Y; Gao P; Lu J; Li X; Liu D
Int Immunopharmacol; 2015 Feb; 24(2):153-158. PubMed ID: 25499727
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of cytochrome P450 3A74 CRISPR/Cas9 knockout bovine foetal hepatocyte cell line (BFH12).
Iori S; D'Onofrio C; Laham-Karam N; Mushimiyimana I; Lucatello L; Montanucci L; Lopparelli RM; Bonsembiante F; Capolongo F; Pauletto M; Dacasto M; Giantin M
Biochem Pharmacol; 2024 Jun; 224():116231. PubMed ID: 38648904
[TBL] [Abstract][Full Text] [Related]
19. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.
Ling K; Yang L; Yang N; Chen M; Wang Y; Liang S; Li Y; Jiang L; Yan P; Liang Z
Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837
[TBL] [Abstract][Full Text] [Related]
20. Construction and Evaluation of a Novel Organic Anion Transporter 1/3 CRISPR/Cas9 Double-Knockout Rat Model.
Gou X; Ran F; Yang J; Ma Y; Wu X
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
